Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · IEX Real-Time Price · USD
11.50
-1.20 (-9.45%)
At close: May 17, 2024, 4:00 PM
11.60
+0.10 (0.87%)
After-hours: May 17, 2024, 7:54 PM EDT
Candel Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Candel Therapeutics stock has a target of 11, which predicts a decrease of -4.35% from the current stock price of 11.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 13, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for CADL is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | -4.35% | Nov 13, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | -4.35% | May 22, 2023 |
| BMO Capital | BMO Capital | Buy Maintains $9 → $3 | Buy | Maintains | $9 → $3 | -73.91% | May 15, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | -39.13% | Mar 31, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | -30.43% | Dec 7, 2022 |
Financial Forecast
Revenue This Year
110.50K
Revenue Next Year
n/a
from 110.50K
EPS This Year
-0.81
from -1.31
EPS Next Year
-0.93
from -0.81
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | n/a | 25.5M |
| Avg | n/a | 24.8M |
| Low | n/a | 23.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -0.96 | -0.47 |
| Avg | -0.93 | -0.45 |
| Low | -0.89 | -0.43 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.